Hetero Labs V Biologic Avanafil Receives Approval in US
14 Jun 2024 //
FDA
Petros Pharma`s STENDRA Tablets Reported Improvement in Erectile Function
08 Sep 2022 //
PRESS RELEASE
Petros Pharma Announces Positive Results of OTC Label Comprehension Study
19 Apr 2022 //
GLOBENEWSWIRE
Petros Partners with Global Contract Manufacturer for STENDRA`s production
24 Jan 2022 //
PRNEWSWIRE
Petros Pharma Launches Two Self-Selection Studies for STENDRA
18 Jan 2022 //
PRNEWSWIRE
Petros Pharmaceuticals Reports Q3 Financial Results, Provides Corporate Update
15 Nov 2021 //
PRNEWSWIRE
Petros Partners with Hims & Hers Health Generates 476% Growth of STENDRA Sales
03 Nov 2021 //
PRNEWSWIRE
Petros Completes Pilot Label Comprehension Study to Start Process for Stendra®
13 Jul 2021 //
PRNEWSWIRE
Petros Establishes Steering Committee to Expand into Non-Rx Status for Stendra®
04 Feb 2021 //
PRNNEWSWIRE
Neurotrope & Metuchen Pharmac Announce Merger Agreement to Form Petros
18 May 2020 //
PRNEWSWIRE
Obliterated by Alzheimer`s failure, Neurotrope relinquishes reverse merger
18 May 2020 //
ENDPTS
Acerus Receives Notice of Deficiency From Health Canada Regarding Avanafil
20 Apr 2020 //
BUSINESSWIRE
Metuchen Pharmaceuticals, LLC. receives FDA Warning Letter
03 Sep 2019 //
FDA
FDA`s OPDP Warns Metuchen Pharmaceuticals Over Misleading DTC Ads
27 Aug 2019 //
RAPS
STENDRA (avanafil): Metuchen Pharma, Mitsubishi Tanabe Pharma vs. Empower Pharma
24 Nov 2018 //
PATENT LITIGATION
STENDRA® (avanafil): Metuchen Pharmaceuticals LLC v. Empower Pharmaceuticals LLC et al
09 Jul 2018 //
PATENT LITIGATION
Sanofi, following in Endo`s footsteps, back rights to Vivus on ED med Stendra
29 Mar 2017 //
FIERCE PHARMA
Sanofi gives up certain regional rights to Stendra
28 Mar 2017 //
THE PHARMALETTER
Post-Endo pact, will Vivus go it alone on U.S. Stendra marketing--and should it?
05 Aug 2016 //
FIERCE PHARMA
Menarini AP to market Mitsubishi Tanabe`s Spedra in 10 Asia-Pacific countries
29 Feb 2016 //
PHARMABIZ
Pharma ad budgets stay flat, even as spending jumps across the board
09 Dec 2015 //
FIERCE PHARMA MARKETING
Endo plots a relaunch of Auxilium`s ED med, complete with new salesforce and DTC
13 May 2015 //
FIERCE PHARMA MARKETING
FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex`s Kaldeco
11 Mar 2015 //
RAPS
Endo ends Stendra marketing pact, leaving Vivus in the lurch
05 Jan 2015 //
FIERCE PHARMA MARKETING